Human Leukocyte Antigen-G (HLA-G) 14-bp deletion polymorphism is associated with decreased risk of pulmonary fibrosis in Indonesian Javanese patients with multidrug-resistant tuberculosis

1Koul A, Arnoult E, Lourds N, Guillemont J, Andries K. The challenge of new drug discovery for tuberculosis. Nature. 2011; 469:483-90.2127088610.1038/nature09657KoulAArnoultELourdsNGuillemontJAndriesKThe challenge of new drug discovery for tuberculosisNature20114694839021270886Search in Google Scholar

2Kleinnijenhuis J, Oosting M, Joosten LAB, Netea MG Van Crevel R. Innate immune recognition of Mycobacterium tuberculosis. J Immunol Res. 2011; 2011:405310.KleinnijenhuisJOostingMJoostenLABNeteaMG Van Crevel RInnate immune recognition of Mycobacterium tuberculosisJ Immunol Res20112011405310Search in Google Scholar

3Sotgiu G, Centis R, D’Ambrosio L, Alffenaar JWC Anger HA, Caminero JA, et al. Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB : systematic review and metaanalysis. Eur Respiri. 2012; 40:1430-42.10.1183/09031936.00022912SotgiuGCentisRD’AmbrosioLAlffenaarJWC Anger HACamineroJAet alEfficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB : systematic review and metaanalysisEur Respiri20124014304222496332Open DOISearch in Google Scholar

4Glaziou P, Falzon D, Floyd K, Raviglione M. Global epidemiology of tuberculosis. SeminRespir Crit Care Med. 2013; 34:3-16.GlaziouPFalzonDFloydKRaviglioneMGlobal epidemiology of tuberculosisSeminRespir Crit Care Med20133431610.1007/978-3-030-66703-0_37Search in Google Scholar

5World Health Organization (WHO). Global tuberculosis report 2014. WHO/HTM/TB/2014.08.2014. p. 7-31.World Health Organization (WHO)Global tuberculosis report 2014WHO/HTM/TB/2014.082014731Search in Google Scholar

6Cohen T, Jenkins HE, Lu C, McLaughlin M, Floyd K, Zignol M. On the spread and control of MDR-TB epidemics: An examination of trends in antituberculosis drug resistance surveillance data. Drug Resist Updat. 2014; 17:105-23.2545878310.1016/j.drup.2014.10.001CohenTJenkinsHELuCMcLaughlinMFloydKZignolMOn the spread and control of MDR-TB epidemics: An examination of trends in antituberculosis drug resistance surveillance dataDrug Resist Updat20141710523435829925458783Search in Google Scholar

7Park CK, Kwon YS. Respiratory review of 2014: tuberculosis and nontuberculous mycobacterial pulmonary disease. TubercRespirDis. 2014; 77:161-6.ParkCKKwonYSRespiratory review of 2014: tuberculosis and nontuberculous mycobacterial pulmonary diseaseTubercRespirDis201477161610.4046/trd.2014.77.4.161421703125368661Search in Google Scholar

8Cassir N, Rolain J-M, Brouqui P. A new strategy to fight antimicrobial resistance: the revival of old antibiotics. Front Microbiol. 2014; 5:551.CassirNRolainJ-MBrouquiPA new strategy to fight antimicrobial resistance: the revival of old antibioticsFront Microbiol2014555110.3389/fmicb.2014.00551420270725368610Search in Google Scholar

9Soini H, Vasankari T. MDR tuberculosis. Duodecim. 2014; 130:1599-605.25269365SoiniHVasankariTMDR tuberculosisDuodecim20141301599605Search in Google Scholar

10Muller B, Borrell S, Rose G, Gagneux S. The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis. Trends Genet TIG. 2013;29:160-9.10.1016/j.tig.2012.11.005MullerBBorrellSRoseGGagneuxSThe heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosisTrends Genet TIG2013291609359455923245857Open DOISearch in Google Scholar

11Dean AS, Zignol M, Falzon D, Getahun H, Floyd K. HIV and multidrug-resistant tuberculosis: overlapping epidemics. EurRespir J. 2014; 44:251-4.DeanASZignolMFalzonDGetahunHFloydKHIV and multidrug-resistant tuberculosis: overlapping epidemicsEurRespir J201444251410.1183/09031936.0020541324525438Search in Google Scholar

12Bezu H, Seifu D, Yimer G Mebrhatu T. Prevalence and risk factors of adverse drug reactions associated multidrug resistant tuberculosis treatments in selected treatment centers in Addis Ababa Ethiopia. J Tuberc Res. 2014; 2:144-54.10.4236/jtr.2014.23018BezuHSeifuDYimerG Mebrhatu TPrevalence and risk factors of adverse drug reactions associated multidrug resistant tuberculosis treatments in selected treatment centers in Addis Ababa EthiopiaJ Tuberc Res2014214454Open DOISearch in Google Scholar

13Vannberg FO, Chapman S J, Hill AVS. Human genetic susceptibility to intracellular pathogens. Immunol Rev.2011;240:105-16.10.1111/j.1600-065X.2010.00996.x21349089VannbergFOChapmanS JHillAVSHuman genetic susceptibility to intracellular pathogensImmunol Rev20112401051621349089Open DOISearch in Google Scholar

14Peresi E, Oliveira LRC, da Silva WL, da Costa EA Araujo JP Jr, Ayres JA, et al. Cytokine polymorphisms, their influence and levels in Brazilian patients with pulmonary tuberculosis during antituberculosis treatment. Tuberc Res Treat. 2013 ; 2013 :e285094.PeresiEOliveiraLRCdaSilva WLdaCosta EA Araujo JPJrAyresJAet alCytokine polymorphisms, their influence and levels in Brazilian patients with pulmonary tuberculosis during antituberculosis treatmentTuberc Res Treat20132013e28509410.1155/2013/285094361963423634300Search in Google Scholar

15Sadki K, Bakri Y, Tijane Mh, Amzazi S. MHC polymorphism and tuberculosis disease. In Cardona P-J, editor. Understanding tuberculosis - analyzing the origin of mycobacterium tuberculosis pathogenicity [online] 2012. [cited 2014 Oct 12]. Available from:http://www.intechopen.com/books/understanding-tuberculosis-analyzing-the-origin-of-mycobacteriumtuberculosis-pathogenicity/mhc-polymorphism-and-tuberculosis-disease.SadkiKBakriYTijaneMhAmzaziSUnderstanding tuberculosis - analyzing the origin of mycobacterium tuberculosis pathogenicity [online] 2012MHC polymorphism and tuberculosis diseaseCardonaP-JInCardonaP-JeditorUnderstanding tuberculosis - analyzing the origin of mycobacterium tuberculosis pathogenicity [online] 2012[cited 2014 Oct 12]Available fromhttp://www.intechopen.com/books/understanding-tuberculosis-analyzing-the-origin-of-mycobacteriumtuberculosis-pathogenicity/mhc-polymorphism-and-tuberculosis-disease10.5772/29742Search in Google Scholar

16Fainardi E, Castellazzi M, Stignani M, Morandi F, Sana G, Gonzalez R, et al. Emerging topics and new perspectives on HLA-G. Cell Mol Life Sci. 2011; 68:433-51.10.1007/s00018-010-0584-321080027FainardiECastellazziMStignaniMMorandiFSanaGGonzalezRet alEmerging topics and new perspectives on HLA-GCell Mol Life Sci2011684335121080027Open DOISearch in Google Scholar

17Donadi EA, Castelli EC, Arnaiz-Villena A, Roger M, Rey D, Moreau P. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci. 2011; 68:369-95.2110763710.1007/s00018-010-0580-7DonadiEACastelliECArnaiz-VillenaARogerMReyDMoreauPImplications of the polymorphism of HLA-G on its function, regulation, evolution and disease associationCell Mol Life Sci20116836995302119521107637Search in Google Scholar

18Amiot L, Ferrane S, Grosse-Wilde H, Seliger B. Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?. Cell Mol Life Sci. 2011; 68:417-31.10.1007/s00018-010-0583-4AmiotLFerraneSGrosse-WildeHSeligerBBiology of HLA-G in cancer: a candidate molecule for therapeutic intervention?Cell Mol Life Sci20116841731342623821063893Open DOISearch in Google Scholar

19Carosella ED, Gregori S, Rouas-Freiss N, LeMaoult J, Menier C, Favier B. The role of HLA-G in immunity andhematopoiesis. Cell Mol Life Sci. 2011; 68:353-68.10.1007/s00018-010-0579-021116680CarosellaEDGregoriSRouas-FreissNLeMaoultJMenierCFavierBThe role of HLA-G in immunity andhematopoiesisCell Mol Life Sci2011683536821116680Open DOISearch in Google Scholar

20Celsi F, Catamo E, Kleiner G, Tricarico PM, Vuch J, Crovella S. HLA-G/C, miRNAs, and their role in HIV infection and replication. BioMed Res Int. 2013; 2013:693643.23841087CelsiFCatamoEKleinerGTricaricoPMVuchJCrovellaSHLA-G/C, miRNAs, and their role in HIV infection and replicationBioMed Res Int2013201369364310.1155/2013/693643369713823841087Search in Google Scholar

21Naji A, Menier C, Morandi F, Agaugue S, Maki G, Ferretti E, et al. Binding of HLA-G to ITIM-Bearing Ig-like transcript 2 receptor suppresses B cell responses. J Immunol. 2014; 192:1536-46.10.4049/jimmunol.130043824453251NajiAMenierCMorandiFAgaugueSMakiGFerrettiEet alBinding of HLA-G to ITIM-Bearing Ig-like transcript 2 receptor suppresses B cell responsesJ Immunol201419215364624453251Open DOISearch in Google Scholar

22Agaugué S, Carosella ED, Rouas-Freiss N. Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Thl/Thl7. Blood. 2011;117:7021-31.10.1182/blood-2010-07-294389AgauguéSCarosellaEDRouas-FreissNRole of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Thl/Thl7Blood201111770213121482709Open DOISearch in Google Scholar

23Rouas-Freiss N, Moreau P, LeMaoult J, Carosella ED. The dual role of HLA-G in cancer. J Immunol Res. 2014; 2014:359748.24800261Rouas-FreissNMoreauPLeMaoultJCarosellaEDThe dual role of HLA-G in cancerJ Immunol Res2014201435974810.1155/2014/359748399510024800261Search in Google Scholar

24da Silva GK, Vianna P, Veit TD, Crovella S, Catamo E, Cordero EA, et al. Influence of HLA-G polymorphisms in human immunodeficiency virus infection and hepatitis C virus co-infection in Brazilian and Italian individuals. Infect Genet Evol. 2014; 21:418-23.2438911910.1016/j.meegid.2013.12.013daSilva GKViannaPVeitTDCrovellaSCatamoECorderoEAet alInfluence of HLA-G polymorphisms in human immunodeficiency virus infection and hepatitis C virus co-infection in Brazilian and Italian individualsInfect Genet Evol20142141823Search in Google Scholar

25Morandi F, Fainardi E, Rizzo R, Rouas-Freiss N. The role of HLA-Class Ib molecules in immune-related diseases, tumors, and infections. J Immunol Res. 2014; 2014:231618.24982921MorandiFFainardiERizzoRRouas-FreissNThe role of HLA-Class Ib molecules in immune-related diseases, tumors, and infectionsJ Immunol Res2014201423161810.1155/2014/231618Search in Google Scholar

26Bradfute SB, Castillo EF, Arko-Mensah J, Chauhan S, Jiang S, Mandeli M, et al. Autophagy as an immune effector against tuberculosis. Curr Opin Microbiol. 2013; 16:355-65.10.1016/j.mib.2013.05.00323790398BradfuteSBCastilloEFArko-MensahJChauhanSJiangSMandeliMet alAutophagy as an immune effector against tuberculosisCurr Opin Microbiol20131635565Open DOISearch in Google Scholar

27Hviid TV, Hylenius S, Hoegh AM, Kruse C, Christiansen OB. HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens. 2002; 60: 122-32.10.1034/j.1399-0039.2002.600202.x12392506HviidTVHyleniusSHoeghAMKruseCChristiansenOBHLA-G polymorphisms in couples with recurrent spontaneous abortionsTissue Antigens20026012232Open DOISearch in Google Scholar

28Pangault C, Le Friec G, Caulet-Maugendre S, Lena H, Amiot L, Guilloux V, et al. Lung macrophages and dendritic cells express HLA-G molecules in pulmonary diseases. Hum Immunol. 2002; 63:83-90.10.1016/S0198-8859(01)00373-111821155PangaultCLeFriec GCaulet-MaugendreSLenaHAmiotLGuillouxVet alLung macrophages and dendritic cells express HLA-G molecules in pulmonary diseasesHum Immunol2002638390Open DOISearch in Google Scholar

29Marchesi M, Andersson E, Villabona L, Seliger B, Lundqvist A, Kiessling R, et al. HLA-dependent tumour development: a role for tumour associate macrophages?. J Transl Med. 2013; 11:247.2409345910.1186/1479-5876-11-247MarchesiMAnderssonEVillabonaLSeligerBLundqvistAKiesslingRet alHLA-dependent tumour development: a role for tumour associate macrophages?J Transl Med201311247385651924093459Search in Google Scholar

30McIntire RH, Hunt JS. Antigen presenting cells and HLA-G-a review. Placenta. 2005; 26 Suppl A:S104-9.McIntireRHHuntJSAntigen presenting cells and HLA-G-a reviewPlacenta200526 Suppl AS104910.1016/j.placenta.2005.01.00615837058Search in Google Scholar

31Twito T, Joseph J, Mociornita A, Rao V, Ross H, Delgado DH. The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients. J Heart Lung Transplant. 2011; 30:778-82.2148214910.1016/j.healun.2011.01.726TwitoTJosephJMociornitaARaoVRossHDelgadoDHThe 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipientsJ Heart Lung Transplant2011307788221482149Search in Google Scholar

32Castelli EC, Mendes-Junior CT, Veiga-Castelli LC, Roger M, Moreau P, Donadi EA. A comprehensive study of polymorphic sites along the HLA-G gene: implication for gene regulation and evolution. Mol Biol Evol. 2011 ; 28:3069-86.10.1093/molbev/msr13821622995CastelliECMendes-JuniorCTVeiga-CastelliLCRogerMMoreauPDonadiEAA comprehensive study of polymorphic sites along the HLA-G gene: implication for gene regulation and evolutionMol Biol Evol20112830698621622995Open DOISearch in Google Scholar

33Eskandari-Nasab E, Hashemi M, Hasani SS, Omrani M, Taheri M, Mashhadi MA. Association between HLA-G 3’UTR 14-bp ins/del polymorphism and susceptibility to breast cancer. Cancer Biomark. 2013; 13:253-9.2424058610.3233/CBM-130364Eskandari-NasabEHashemiMHasaniSSOmraniMTaheriMMashhadiMAAssociation between HLA-G 3’UTR 14-bp ins/del polymorphism and susceptibility to breast cancerCancer Biomark201313253924240586Search in Google Scholar